Literature DB >> 21861233

Distance of breast cancer from the skin and nipple impacts axillary nodal metastases.

Bijan Ansari1, Marilyn J Morton, Darcy L Adamczyk, Katie N Jones, Julie K Brodt, Amy C Degnim, James W Jakub, Christine M Lohse, Judy C Boughey.   

Abstract

BACKGROUND: Lymphatic drainage of the breast is via subareolar and dermal lymphatics. The aim of this study was to determine whether distance of breast cancers from the skin and/or distance from the nipple impacts the likelihood of axillary nodal metastases.
METHODS: A retrospective review was performed of sonographically visible T1 and T2 breast cancers with breast and axillary surgery performed at Mayo Clinic, Rochester, MN. Distance of tumor from the nipple was reviewed. Ultrasounds were reviewed to measure the distance of tumor from the skin.
RESULTS: Data were collected on 233 eligible T1 or T2 breast cancers, of which 177 (76%) were node negative and 56 (24%) were node positive. On multivariable analysis, tumor stage and lymphovascular invasion, as well as decreasing distance of the tumor from the nipple and decreasing distance of the tumor from the skin, were significantly associated with axillary lymph node positivity. Each 1-cm decrease in the distance of the tumor from the nipple was associated with a 23% increased likelihood of positive lymph nodes (odds ratio 1.23; P = .003). Each 1-mm decrease in the distance of the tumor from the skin was associated with a 15% increased likelihood of positive lymph nodes (odds ratio 1.15; P = .003).
CONCLUSION: T1 and T2 breast cancers located closer to the skin and those located closer to the nipple have a higher incidence of metastases to axillary lymph nodes. Distance from the skin and distance from the nipple should be considered when estimating a patient's likelihood of axillary nodal positivity.

Entities:  

Mesh:

Year:  2011        PMID: 21861233     DOI: 10.1245/s10434-011-1957-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Feasibility of spatial frequency-domain imaging for monitoring palpable breast lesions.

Authors:  Constance M Robbins; Guruprasad Raghavan; James F Antaki; Jana M Kainerstorfer
Journal:  J Biomed Opt       Date:  2017-08       Impact factor: 3.170

2.  Tumor location of the central and nipple portion is associated with impaired survival for women with breast cancer.

Authors:  Fei Ji; Wei-Kai Xiao; Ci-Qiu Yang; Mei Yang; Liu-Lu Zhang; Hong-Fei Gao; Yu-Feng Lin; Teng Zhu; Min-Yi Cheng; Wei-Ping Li; Wei-Jun Pan; Xiao-Sheng Zhuang; Kun Wang
Journal:  Cancer Manag Res       Date:  2019-04-09       Impact factor: 3.989

3.  Distance Between the Tumour and Nipple as a Predictor of Axillary Lymph Node Involvement in Breast Cancer.

Authors:  Jiqiao Yang; Qianru Yang; Arjudeb Mukherjee; Qing Lv
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

4.  Predictive Factors Among Clinicopathological Characteristics for Sentinel Lymph Node Metastasis in T1-T2 Breast Cancer.

Authors:  Shigeki Minami; Chika Sakimura; Junji Irie; Yukiko Tokai; Hitoshi Okubo; Tsuyoshi Ohno
Journal:  Cancer Manag Res       Date:  2021-01-11       Impact factor: 3.989

5.  Predictive performance of ultrasonography-based radiomics for axillary lymph node metastasis in the preoperative evaluation of breast cancer.

Authors:  Si Eun Lee; Yongsik Sim; Sungwon Kim; Eun-Kyung Kim
Journal:  Ultrasonography       Date:  2020-04-01

6.  Deep Learning Mechanism for Predicting the Axillary Lymph Node Metastasis in Patients with Primary Breast Cancer.

Authors:  N Ashokkumar; S Meera; P Anandan; Mantripragada Yaswanth Bhanu Murthy; K S Kalaivani; Tahani Awad Alahmadi; Sulaiman Ali Alharbi; S S Raghavan; S Arockia Jayadhas
Journal:  Biomed Res Int       Date:  2022-08-10       Impact factor: 3.246

7.  Real-world outcomes for Chinese breast cancer patients with tumor location of central and nipple portion.

Authors:  Wei-Da Fu; Xiao-Hui Wang; Kang-Kang Lu; Yi-Qiao Lu; Jie-Yu Zhou; Qi-Di Huang; Gui-Long Guo
Journal:  Front Surg       Date:  2022-10-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.